Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2022-06-25
2022-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Astaxanthin Supplementation
NCT06511960
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
NCT03368872
Impact of Astaxanthin on Cognition in Recreationally Active Females
NCT06460181
Astaxanthin Reduces Exercising Heart Rate.
NCT05282355
Astaxanthin Supplementation in Cyclists
NCT01241877
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
containing edible yellow No. 4, edible yellow No. 5, sucrose, silica, talc, oxidized starch, gelatin, magnesium stearate, and palm wax.
Placebo (Placebo trial)
The Placebo capsule supplement was taken for 4 days (7 capsules per day)
Astaxanthin (AST trial)
The AST capsule supplement was taken for 4 days, with a daily dosage of 28 mg of AST (equivalent to 7 capsules per day, each containing 4 mg of AST).
Astaxanthin (AST)
Each capsule containing 4 mg of AST
Placebo (Placebo trial)
The Placebo capsule supplement was taken for 4 days (7 capsules per day)
Astaxanthin (AST trial)
The AST capsule supplement was taken for 4 days, with a daily dosage of 28 mg of AST (equivalent to 7 capsules per day, each containing 4 mg of AST).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo (Placebo trial)
The Placebo capsule supplement was taken for 4 days (7 capsules per day)
Astaxanthin (AST trial)
The AST capsule supplement was taken for 4 days, with a daily dosage of 28 mg of AST (equivalent to 7 capsules per day, each containing 4 mg of AST).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those who have implanted artificial joints in the past six months and have had recent surgery.
* People who feel unwell due to other reasons during the experiment.
* Take any drugs or Nutrition supplements in the past 3 months.
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Science and Technology Council
FED
China Medical University, China
OTHER
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Piao Tsao
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung-Piao Tsao
Role: STUDY_CHAIR
China Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tsao JP, Wu PY, Kuo HT, Hong WH, Chen CC, Wang MY, Korivi M, Cheng IS. Effect of astaxanthin supplementation on cycling performance, muscle damage biomarkers and oxidative stress in young adults: a randomized controlled trial. BMC Sports Sci Med Rehabil. 2025 Jul 4;17(1):180. doi: 10.1186/s13102-025-01221-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH111-REC3-081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.